Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

Hepatology

Volumn 30, Issue 3, 1999, Pages 770-774

  Chien, Rong Nan ^a   Liaw, Yun Fan ^a,c   Atkins, Mark ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b GLAXOSMITHKLINE   (United Kingdom)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY FLUID; CHRONIC HEPATITIS; DISEASE MARKER; FEMALE; GENDER; HEPATITIS B; HUMAN; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROCONVERSION;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE;

EID: 0032869876     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300313     Document Type: Article

References (16)

1. Doong SL., Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′ thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991;88:8495-8499.
2. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-1661.
3. Nevens F, Main J, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, Fevery J, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997; 113:1258-1263.
4. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998;102:1-8.
5. Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
6. Zoulim F, Trepo C. Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 1998;29:151-168.
7. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B; a meta-analysis. Ann Intern Med 1993; 119:312-323.
8. Liaw YE Current trends in therapy for chronic viral hepatitis. J Gastroenterol Hepatol 1997;12:S346-S353.
9. Lok ASF, Chang MG, Watson G, Ayola B. Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B. J Viral Hepat 1998;5:171-178.
10. Liaw YF, Tsai SL. Pathogenesis and clinical significance of acute exacerbations and remissions in patients with chronic hepatitis B virus infection. Viral Hep Rev 1997;3:143-154.
11. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990;175:255-261.
12. Fourel I, Cullen J, Saputelli J, Aldrich C, Schaffer P, Averett D, Pugh J, et al. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol 1994;68:8321-8330.
13. Mason WS, Cullen J, Moraleda G, Saputelli J, Aldrich CE, Miller DS, Tennant B, et al. Lamivudine therapy of WHV-infected woodchucks. Virology 1998;245;18-32.
14. Schiff E, Cianciara J, Kowdley K, Norkrans G, Perillo R, Tong M, Crowther L, et al. Durability of HbeAg seroconversion after lamivudine monotherapy in controlled phase II and III trials [Abstr]. HEPATOLOGY 1998;28(Suppl):163A.
15. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. HEPATOLOGY 1999; 30 (in press).
16. Liaw YF, Lai CL, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. Two year lamivudine therapy in chronic hepatitis B infection: results of a placebo controlled multicenter study in Asia [Abstract]. Gastroenterology 1998;114:A1289.